|
CN104860975A
|
|
Bortezomib synthesis intermediate preparation method
|
|
CN104829633A
|
|
Preparation method of high-purity biapenem
|
|
CN104650012A
|
|
Taxane compound
|
|
CN104650109A
|
|
Taxane compound
|
|
CN103896862A
|
|
Method for preparing gefitinib Form I crystal form
|
|
CN104447867A
|
|
Thienopiperidine derivative, preparation method and application thereof
|
|
CN104230932A
|
|
Matrine derivatives as well as preparation method and application of matrine derivatives
|
|
CN104230931A
|
|
Sophoridine derivatives, and preparation method and application thereof
|
|
CN104181270A
|
|
Temozolomide suppository content measuring method by utilization of reversed-phase ion-pair chromatography method
|
|
CN104173338A
|
|
Suppository used for treating cancer
|
|
CN103772256A
|
|
Preparation method for high-purity sulpiride or optical isomers thereof
|
|
CN103664953A
|
|
Preparation method of eszopiclone
|
|
TW201219056A
|
|
Taxanes containing solution and a preparation method of the co-solvent
|
|
TW201219055A
|
|
A taxane-containing drug solution containing chelating agent and a preparation method thereof
|
|
TW201219065A
|
|
A taxane-containing drug solution containing a pH adjusting agent and a preparation method thereof
|
|
CN102038634A
|
|
Cosolvent-containing taxane medicinal solution and preparation method thereof
|
